ATE382624T1 - Kristalle von taxanderivaten und verfahren zu deren herstellung - Google Patents

Kristalle von taxanderivaten und verfahren zu deren herstellung

Info

Publication number
ATE382624T1
ATE382624T1 AT02785977T AT02785977T ATE382624T1 AT E382624 T1 ATE382624 T1 AT E382624T1 AT 02785977 T AT02785977 T AT 02785977T AT 02785977 T AT02785977 T AT 02785977T AT E382624 T1 ATE382624 T1 AT E382624T1
Authority
AT
Austria
Prior art keywords
taxand
crystals
derivatives
production
mixture
Prior art date
Application number
AT02785977T
Other languages
English (en)
Inventor
S Uchida
Y Takayanagi
Makoto Ono
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ATE382624T1 publication Critical patent/ATE382624T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
AT02785977T 2001-11-29 2002-11-29 Kristalle von taxanderivaten und verfahren zu deren herstellung ATE382624T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001363681 2001-11-29

Publications (1)

Publication Number Publication Date
ATE382624T1 true ATE382624T1 (de) 2008-01-15

Family

ID=19173983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02785977T ATE382624T1 (de) 2001-11-29 2002-11-29 Kristalle von taxanderivaten und verfahren zu deren herstellung

Country Status (17)

Country Link
US (1) US7410980B2 (de)
EP (1) EP1457492B1 (de)
JP (1) JP4310191B2 (de)
KR (1) KR100886805B1 (de)
CN (1) CN1295229C (de)
AT (1) ATE382624T1 (de)
AU (1) AU2002354126A1 (de)
CA (1) CA2468953C (de)
DE (1) DE60224440T2 (de)
DK (1) DK1457492T3 (de)
ES (1) ES2299612T3 (de)
MX (1) MXPA04005192A (de)
NO (1) NO328559B1 (de)
PT (1) PT1457492E (de)
RU (1) RU2284328C2 (de)
TW (1) TWI333856B (de)
WO (1) WO2003045953A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
DK1741716T3 (da) 2004-04-30 2011-11-28 Daiichi Sankyo Co Ltd Fremgangsmåde til fremstilling af pentacyklisk taxan
US20070005911A1 (en) * 2005-07-01 2007-01-04 Nec Laboratories America, Inc. Operating System-Based Memory Compression for Embedded Systems
US8785669B2 (en) 2010-06-30 2014-07-22 Gfv, Llc Taxane compounds, compositions and methods
US8697892B2 (en) 2010-06-30 2014-04-15 Gfv, Llc Taxane compounds, compositions and methods
EP2447268A1 (de) * 2010-10-29 2012-05-02 INDENA S.p.A. Kristalline Form von 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III
JP5909089B2 (ja) * 2011-02-01 2016-04-26 アークレイ株式会社 光学結晶、テラヘルツ波発生装置及び方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254515B (it) * 1992-03-06 1995-09-25 Indena Spa Tassani di interesse oncologico, loro metodo di preparazione ed uso
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
BR9608040B1 (pt) * 1995-04-28 2010-02-23 composto taxàide pentacÍclico.
JP2000159757A (ja) * 1998-12-01 2000-06-13 Dai Ichi Seiyaku Co Ltd 7−デオキシタキソール誘導体の製造方法
HK1042302B (en) * 1999-05-17 2004-10-08 Bristol-Myers Squibb Company Novel reaction conditions for the cleavage of silyl ethers in the preparation of paclitaxel (taxol) and paclitaxel analogues
MXPA02003797A (es) 1999-10-15 2002-12-13 Daiichi Seiyaku Co Compuestos de taxano pentaciclico.
US6677456B2 (en) 1999-10-15 2004-01-13 Daiichi Pharmaceutical Co., Ltd. Pentacyclic taxan compound
WO2002070512A1 (en) * 2001-03-07 2002-09-12 Daiichi Pharmaceutical Co, Ltd. Method for producing 2-azetidinone derivative

Also Published As

Publication number Publication date
CA2468953C (en) 2010-05-11
ES2299612T3 (es) 2008-06-01
CN1295229C (zh) 2007-01-17
RU2284328C2 (ru) 2006-09-27
AU2002354126A1 (en) 2003-06-10
CN1596259A (zh) 2005-03-16
JPWO2003045953A1 (ja) 2005-04-07
EP1457492A4 (de) 2005-03-23
NO328559B1 (no) 2010-03-22
US7410980B2 (en) 2008-08-12
RU2004119547A (ru) 2005-03-27
DK1457492T3 (da) 2008-05-13
KR20040081426A (ko) 2004-09-21
TWI333856B (en) 2010-12-01
NO20042723L (no) 2004-06-28
US20050070579A1 (en) 2005-03-31
MXPA04005192A (es) 2005-02-22
DE60224440D1 (de) 2008-02-14
EP1457492A1 (de) 2004-09-15
HK1065547A1 (en) 2005-02-25
DE60224440T2 (de) 2009-01-02
PT1457492E (pt) 2008-02-28
CA2468953A1 (en) 2003-06-05
KR100886805B1 (ko) 2009-03-05
TW200301114A (en) 2003-07-01
WO2003045953A1 (en) 2003-06-05
JP4310191B2 (ja) 2009-08-05
EP1457492B1 (de) 2008-01-02

Similar Documents

Publication Publication Date Title
DE50310783D1 (de) Neue thiophenglycosidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
AU2003213407A1 (en) Dna nanocage by self-organization of dna and process for producing the same, and dna nanotube and molecule carrier using the same
ATE510798T1 (de) Verfahren zur herstellung eines kristallinen, zeolithischen feststoffs
DE50111293D1 (de) Diphenylazetidinonderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DK0552041T3 (da) Enzymatiske fremgangsmåder til spaltning af enantiomerblandinger af forbindelser, der er nyttige som mellemprodukter ved fr
EP1845416A3 (de) Beschichtungszusammensetzungen für Photolithographie
CA2557274A1 (en) Method for producing monatin
GB2394955B (en) Actinic radiation curable composition and actinic radiation curable ink, and image forming method as well as ink jet recording apparatus using the same
DE69418773D1 (de) Eine Silacyclohexanverbindung, ein Verfahren zu deren Herstellung und eine diese enthaltende flüssigkristalline Zusammensetzung
ATE382624T1 (de) Kristalle von taxanderivaten und verfahren zu deren herstellung
DE50313017D1 (de) Ringsubstituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE69910113D1 (de) Verfahren zur Herstellung von Stickstofftrifluorid durch Gas-Feststoffreaktion
ATE176621T1 (de) Verfahren und vorrichtung zum beschichten eines um eine achse rotierenden körpers
AU2003258667A1 (en) Method for the production by fermentation of sulphur-containing fine chemicals (metf)
ATE244263T1 (de) Verfahren zur herstellung von n-glycyltyrosin
DE60105314D1 (de) Verfahren zur herstellung von taxanderivaten
AU2003283305A1 (en) Compounds which can be activated by actinic radiation and contain urethane groups, method for the production thereof and use of the same
DE60315308D1 (de) VERFAHREN ZUR HERSTELLUNG VON 5-(4-FLUORPHENYL)-1-i2-((2R,4R)-4-HYDROXY-6-OXOTETRAHYDROPYRAN-2-YL)ETHYLö-2-ISOPROPYL-4-PHENYL-1H-PYRROL-3-CARBONSÄUREPHENYLAMID
ATE304000T1 (de) Verfahren zur herstellung von n-carboxyanhydriden von aminosäuren
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
DE69830624D1 (de) Verfahren zum Herstellen von organischen Fluorverbindungen
DE60232006D1 (de) Rückgewinnung und recycling chiraler weinsäureverbindungen zur racematspaltung
ATE390406T1 (de) Neue stabile kristalle substituierter phenylpropionsäurederivate und verfahren zu deren herstellung
ATE245161T1 (de) Verfahren zur synthese von phosphororganischen verbindungen
WO2007017244A3 (en) A PROCESS FOR THE PURIFICATION OF SUBSTITUTED 2-(2-PYRIDYLMETHYL)SULFINYL-lH-BENZIMIDAZOLE COMPOUNDS BY PRECIPITATION IN THE PRESENCE OF A QUATERNARY AMMONIUM SALT